Article
Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials
Department of Biostatistics Faculty Publications
Date of this Version
4-1-2019
Document Type
Letter to the Editor
Citation Information
Craig A. Garmendia, Liliana Nassar Gorra, Ana Lucia Rodriguez, Mary Jo Trepka, et al.. "Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials" (2019) Available at: http://works.bepress.com/emir-veledar/395/